Header Logo

Connection

Ross Abrams to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Ross Abrams has written about Combined Modality Therapy.
Ross Abrams
Connection Strength
1.866
Combined Modality Therapy
  1. Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiother Oncol. 2006 Nov; 81(2):163-7.
    View in: PubMed
    Score: 0.271
  2. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985? Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):3-9.
    View in: PubMed
    Score: 0.209
  3. The clinical use of multimodality therapy in the management of cancer. In Vivo. 1994 Nov-Dec; 8(5):635-42.
    View in: PubMed
    Score: 0.118
  4. Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer. Am J Clin Oncol. 2010 Feb; 33(1):101-6.
    View in: PubMed
    Score: 0.085
  5. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009 Jul; 16(7):1751-6.
    View in: PubMed
    Score: 0.081
  6. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008 Jul 20; 26(21):3503-10.
    View in: PubMed
    Score: 0.077
  7. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S30-2.
    View in: PubMed
    Score: 0.064
  8. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Surg Oncol Clin N Am. 2004 Oct; 13(4):621-38, ix.
    View in: PubMed
    Score: 0.059
  9. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):166-71.
    View in: PubMed
    Score: 0.055
  10. Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):31-7.
    View in: PubMed
    Score: 0.052
  11. Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet. 2001 Nov 10; 358(9293):1565-6.
    View in: PubMed
    Score: 0.048
  12. Is there a role for radiotherapy in the management of upper gastrointestinal malignancies? Surg Oncol Clin N Am. 2000 Jul; 9(3):525-38, ix.
    View in: PubMed
    Score: 0.044
  13. Metastatic nonresectable fibrolamellar hepatoma: prognostic features and natural history. Am J Clin Oncol. 1999 Feb; 22(1):22-8.
    View in: PubMed
    Score: 0.040
  14. Adjuvant therapy for pancreatic cancer: back to the future. Int J Radiat Oncol Biol Phys. 1998 Aug 01; 42(1):59-63.
    View in: PubMed
    Score: 0.038
  15. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center. Cancer J Sci Am. 1998 May-Jun; 4(3):178-84.
    View in: PubMed
    Score: 0.038
  16. ACR Appropriateness Criteria? Resectable Pancreatic Cancer. Am J Clin Oncol. 2017 Apr; 40(2):109-117.
    View in: PubMed
    Score: 0.035
  17. Comparison of investigator-delineated gross tumour volumes and quality assurance in pancreatic cancer: Analysis of the on-trial cases for the SCALOP trial. Radiother Oncol. 2016 08; 120(2):212-6.
    View in: PubMed
    Score: 0.033
  18. Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head. Surg Clin North Am. 1995 Oct; 75(5):925-38.
    View in: PubMed
    Score: 0.032
  19. Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas. Clin Cancer Res. 2015 Dec 15; 21(24):5612-8.
    View in: PubMed
    Score: 0.031
  20. Improved survival for hepatocellular cancer with combination surgery and multimodality treatment. Ann Surg. 1993 Feb; 217(2):149-54.
    View in: PubMed
    Score: 0.026
  21. Recent developments in radiotherapy. Curr Opin Oncol. 1992 Dec; 4(6):1099-107.
    View in: PubMed
    Score: 0.026
  22. Radiation therapy for heterotopic ossification prophylaxis afer high-risk elbow surgery. Am J Orthop (Belle Mead NJ). 2011 Aug; 40(8):400-5.
    View in: PubMed
    Score: 0.024
  23. Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86.
    View in: PubMed
    Score: 0.023
  24. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol. 2011 May; 18(5):1319-26.
    View in: PubMed
    Score: 0.023
  25. A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation. Ann Surg. 2011 Feb; 253(2):328-35.
    View in: PubMed
    Score: 0.023
  26. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
    View in: PubMed
    Score: 0.022
  27. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
    View in: PubMed
    Score: 0.022
  28. Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma. Ann Oncol. 2010 Jun; 21(6):1203-1210.
    View in: PubMed
    Score: 0.021
  29. Variation in post-surgical lumpectomy cavity volume with delay in initiation of breast irradiation because of chemotherapy. Int J Radiat Oncol Biol Phys. 2010 Jul 01; 77(3):831-5.
    View in: PubMed
    Score: 0.021
  30. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008 Dec 20; 26(36):5918-22.
    View in: PubMed
    Score: 0.020
  31. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008 Mar 05; 299(9):1019-26.
    View in: PubMed
    Score: 0.019
  32. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol. 1986 Oct; 4(10):1443-54.
    View in: PubMed
    Score: 0.017
  33. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. J Clin Oncol. 2005 Aug 01; 23(22):4991-8.
    View in: PubMed
    Score: 0.015
  34. The hematopoietic toxicity of regional radiation therapy. Correlations for combined modality therapy with systemic chemotherapy. Cancer. 1985 Apr 01; 55(7):1429-35.
    View in: PubMed
    Score: 0.015
  35. A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):965-6.
    View in: PubMed
    Score: 0.015
  36. Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12. Am J Clin Oncol. 2004 Feb; 27(1):51-6.
    View in: PubMed
    Score: 0.014
  37. Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610. J Clin Oncol. 2003 Apr 01; 21(7):1238-48.
    View in: PubMed
    Score: 0.013
  38. Acute and late radiotherapy toxicity in patients with inflammatory bowel disease. Int J Radiat Oncol Biol Phys. 2001 Oct 01; 51(2):455-9.
    View in: PubMed
    Score: 0.012
  39. Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation. J Clin Oncol. 2001 Jan 01; 19(1):145-56.
    View in: PubMed
    Score: 0.011
  40. Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):19-27.
    View in: PubMed
    Score: 0.011
  41. Is there a role for surgical resection in the treatment of early-stage pancreatic lymphoma? J Am Coll Surg. 2000 Mar; 190(3):319-30.
    View in: PubMed
    Score: 0.011
  42. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 1997 May-Jun; 3(3):144-52.
    View in: PubMed
    Score: 0.009
  43. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May; 225(5):621-33; discussion 633-6.
    View in: PubMed
    Score: 0.009
  44. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):143-50.
    View in: PubMed
    Score: 0.008
  45. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol. 1996 Feb; 14(2):556-64.
    View in: PubMed
    Score: 0.008
  46. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 1995 Apr; 45(4):616-23.
    View in: PubMed
    Score: 0.008
  47. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. J Clin Oncol. 1993 Apr; 11(4):698-703.
    View in: PubMed
    Score: 0.007
  48. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group. Cancer Treat Rep. 1986 Oct; 70(10):1219-20.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.